| 1 |
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries [J]. JAMA, 2016, 315(8): 788-800.
|
| 2 |
Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes [J]. Lancet (London, England), 2022, 400(10358): 1145-1156.
|
| 3 |
Cioccari L, Luethi N, Masoodi M. Lipid mediators in critically ill patients: a step towards precision medicine [J]. Front Immunol, 2020, 11: 599853.
|
| 4 |
Yang K, Han X. Lipidomics: techniques, applications, and outcomes related to biomedical sciences [J]. Trends Biochem Sci, 2016, 41(11): 954-969.
|
| 5 |
Khaing P, Pandit P, Awsare B, et al. Pulmonary circulation in obesity, diabetes, and metabolic syndrome [J]. Compr Physiol, 2019, 10(1): 297-316.
|
| 6 |
Varela ML, Mogildea M, Moreno I, et al. Acute inflammation and metabolism [J]. Inflammation, 2018, 41(4): 1115-1127.
|
| 7 |
Glasser JR, Mallampalli RK. Surfactant and its role in the pathobiology of pulmonary infection [J]. Microbes Infect, 2012, 14(1): 17-25.
|
| 8 |
Griese M. Pulmonary surfactant in health and human lung diseases: state of the art [J]. Eur Respir J, 1999, 13(6): 1455-1476.
|
| 9 |
Numata M, Chu HW, Dakhama A, et al. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection [J]. Proc Natl Acad Sci USA, 2010, 107(1): 320-325.
|
| 10 |
Perino J, Crouzier D, Spehner D, et al. Lung surfactant DPPG phospholipid inhibits vaccinia virus infection [J]. Antiviral Res, 2011, 89(1): 89-97.
|
| 11 |
Numata M, Kandasamy P, Nagashima Y, et al. Phosphatidylglycerol suppresses influenza A virus infection [J]. Am J Respir Cell Mol Biol, 2012, 46(4): 479-487.
|
| 12 |
Stables MJ, Gilroy DW. Old and new generation lipid mediators in acute inflammation and resolution [J]. Prog Lipid Res, 2011, 50(1): 35-51.
|
| 13 |
Pienkos SM, Moore AR, Guan J, et al. Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials [J]. Crit Care, 2023, 27(1): 126.
|
| 14 |
Yang L, Luo Z, Shi X, et al. Different value of HDL-C in predicting outcome of ARDS secondary to bacterial and viral pneumonia: a retrospective observational study [J]. Heart Lung, 2021, 50(1): 206-213.
|
| 15 |
Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics [J]. J Lipid Res, 2003, 44(6): 1071-1079.
|
| 16 |
Fahy E, Subramaniam S, Brown HA, et al. A comprehensive classification system for lipids [J]. J Lipid Res, 2005, 46(5): 839-861.
|
| 17 |
Harkewicz R, Dennis EA. Applications of mass spectrometry to lipids and membranes [J]. Annu Rev Biochem, 2011, 80: 301-325.
|
| 18 |
Schex R, Lieb VM, Jiménez VM, et al. HPLC-DAD-APCI/ESI-MS(n) analysis of carotenoids and α-tocopherol in Costa Rican Acrocomia aculeata fruits of varying maturity stages [J]. Food Res Int, 2018, 105: 645-653.
|
| 19 |
Kühn C, Von Oesen T, Herz C, et al. In vitro determination of protein conjugates in human cells by LC-ESI-MS/MS after Benzyl Isothiocyanate exposure [J]. J Agric Food Chem, 2018, 66(26): 6727-6733.
|
| 20 |
Shao Y, Zhu B, Zheng R, et al. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery [J]. J Proteome Res, 2015, 14(2): 906-916.
|
| 21 |
Borisjuk L, Rolletschek H, Neuberger T. Nuclear magnetic resonance imaging of lipid in living plants [J]. Prog Lipid Res, 2013, 52(4): 465-487.
|
| 22 |
Li J, Vosegaard T, Guo Z. Applications of nuclear magnetic resonance in lipid analyses: an emerging powerful tool for lipidomics studies [J]. Prog Lipid Res, 2017, 68: 37-56.
|
| 23 |
Han X, Gross RW. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples [J]. Mass Spectrom Rev, 2005, 24(3): 367-412.
|
| 24 |
Lin M, Wang Z, Wang D, et al. Mathematical model-assisted UHPLC-MS/MS method for global profiling and quantification of cholesteryl esters in hyperlipidemic golden hamsters [J]. Anal Chem, 2019, 91(7): 4504-4512.
|
| 25 |
Schlotterbeck J, Chatterjee M, Gawaz M, et al. Comprehensive MS/MS profiling by UHPLC-ESI-QTOF-MS/MS using SWATH data-independent acquisition for the study of platelet lipidomes in coronary artery disease [J]. Anal Chim Acta, 2019, 1046: 1-15.
|
| 26 |
Kim SH, Yang JS, Lee JC, et al. Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer's disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry [J]. J Chromatogr A, 2018, 1568: 91-100.
|
| 27 |
Li Z, Guan M, Lin Y, et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by liver lipidomics [J]. Int J Mol Sci, 2017, 18(12): 2550.
|
| 28 |
Chen Y, Ma Z, Shen X, et al. Serum lipidomics profiling to identify biomarkers for non-small cell lung cancer [J]. Biomed Res Int, 2018, 2018: 5276240.
|
| 29 |
Yang R, Zhang Y, Qian W, et al. Surfactant lipidomics of alveolar lavage fluid in mice based on ultra-high-performance liquid chromatography coupled to hybrid quadrupole-exactive orbitrap mass spectrometry [J]. Metabolites, 2019, 9(4): 80.
|
| 30 |
Gika H, Virgiliou C, Theodoridis G, et al. Untargeted LC/MS-based metabolic phenotyping (metabonomics/metabolomics): the state of the art [J]. J Chromatogr B, Anal Technol Biomed life Sci, 2019, 1117: 136-147.
|
| 31 |
Mandal R, Chamot D, Wishart DS. The role of the human metabolome database in inborn errors of metabolism [J]. J Inherit Metab Dis, 2018, 41(3): 329-336.
|
| 32 |
Hallman M, Spragg R, Harrell JH, et al. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol [J]. J Clin Invest, 1982, 70(3): 673-683.
|
| 33 |
Seeds MC, Grier BL, Suckling BN, et al. Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome [J]. Am J Med Sci, 2012, 343(6): 446-451.
|
| 34 |
Dushianthan A, Goss V, Cusack R, et al. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome [J]. Respir Res, 2014, 15(1): 128.
|
| 35 |
Dushianthan A, Cusack R, Grocott MPW, et al. Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome [J]. J Lipid Res, 2018, 59(6): 1034-1045.
|
| 36 |
Nestel PJ. Fish oil and cardiovascular disease: lipids and arterial function [J]. Am J Clin Nutr, 2000, 71(1 Suppl): 228S-231S.
|
| 37 |
Urakaze M, Hamazaki T, Makuta M, et al. Infusion of fish oil emulsion: effects on platelet aggregation and fatty acid composition in phospholipids of plasma, platelets, and red blood cell membranes in rabbits [J]. Am J Clin Nutr, 1987, 46(6): 936-940.
|
| 38 |
Cotogni P, Trombetta A, Muzio G, et al. The Omega-3 Fatty Acid Docosahexaenoic Acid modulates inflammatory mediator release in human alveolar cells exposed to bronchoalveolar lavage fluid of ARDS Patients [J]. Biomed Res Int, 2015, 2015: 642520.
|
| 39 |
Zhang SY, Shao D, Liu H, et al. Metabolomics analysis reveals that benzo[a]pyrene, a component of PM (2.5), promotes pulmonary injury by modifying lipid metabolism in a phospholipase A2-dependent manner in vivo and in vitro [J]. Redox Biol, 2017, 13: 459-469.
|
| 40 |
Evans CR, Karnovsky A, Kovach MA, et al. Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health [J]. J Proteome Res, 2014, 13(2): 640-649.
|
| 41 |
Bos LDJ, Weda H, Wang Y, et al. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome [J]. Eur Respir J, 2014, 44(1): 188-197.
|
| 42 |
Stringer KA, Jones AE, Puskarich MA, et al. 1H-nuclear magnetic resonance (NMR)-detected lipids associated with apoptosis differentiate early acute respiratory distress syndrome (ARDS) from sepsis [J]. Am J Respir Crit Care Med, 2014, 189: A5000.
|
| 43 |
Rogers AJ, Contrepois K, Wu M, et al. Profiling of ARDS pulmonary edema fluid identifies a metabolically distinct subset [J]. Am J Physiol Lung Cell Mol Physiol, 2017, 312(5): L703-L709.
|
| 44 |
Xu J, Pan T, Qi X, et al. Increased mortality of acute respiratory distress syndrome was associated with high levels of plasma phenylalanine [J]. Respir Res, 2020, 21(1): 99.
|
| 45 |
Alipanah-Lechner N, Neyton L, Mick E, et al. Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDS [J]. Am J Physiol Lung Cell Mol Physiol, 2023, 324(3): L297-L306.
|
| 46 |
Viswan A, Ghosh P, Gupta D, et al. Distinct metabolic endotype mirroring acute respiratory distress syndrome (ARDS) subphenotype and its heterogeneous biology [J]. Sci Rep, 2019, 9(1): 2108.
|
| 47 |
Yan Y, Chen J, Liang Q, et al. Metabolomics profile in acute respiratory distress syndrome by nuclear magnetic resonance spectroscopy in patients with community-acquired pneumonia [J]. Respir Res, 2022, 23(1): 172.
|
| 48 |
Lorente JA, Nin N, Villa P, et al. Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS [J]. Crit Care, 2021, 25(1): 390.
|
| 49 |
Maile MD, Standiford TJ, Engoren MC, et al. Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study [J]. Respir Res, 2018, 19(1): 60.
|
| 50 |
Tao Q, Zhang ZD, Qin Z, et al. Aspirin eugenol ester alleviates lipopolysaccharide-induced acute lung injury in rats while stabilizing serum metabolites levels [J]. Front Immunol, 2022, 13: 939106.
|
| 51 |
Rosas LE, Doolittle LM, Joseph LM, et al. Postexposure liponucleotide prophylaxis and treatment attenuates acute respiratory distress syndrome in influenza-infected mice [J]. Am J Respir Cell Mol Biol, 2021, 64(6): 677-686.
|
| 52 |
Abdulnour RE, Gunderson T, Barkas I, et al. Early intravascular events are associated with development of acute respiratory distress syndrome. A substudy of the LIPS-A clinical trial [J]. Am J Respir Crit Care Med, 2018, 197(12): 1575-1585.
|
| 53 |
Jeon YG, Kim YY, Lee G, et al. Physiological and pathological roles of lipogenesis [J]. Nat Metab, 2023, 5(5): 735-759.
|
| 54 |
Züllig T, Trötzmüller M, Köfeler HC. Lipidomics from sample preparation to data analysis: a primer [J]. Anal Bioanal Chem, 2020, 412(10): 2191-2209.
|